Steffan Daniel Bos

Steffan Daniel Bos

Auto-generated profile, based on publicly available information

Steffan Daniel Bos

Institute of Clinical Medicine, University of Oslo, Norway

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2012 in The Lancet
Verified
Journal Article
Open access
EZEleftheria Zeggini
Eleftheria Zeggini
KPKalliope Panoutsopoulou
Kalliope Panoutsopoulou
LSLorraine Southam
Lorraine Southam
NRNigel W. Rayner
Nigel W. Rayner
ADAaron G. Day-Williams
Aaron G. Day-Williams
JLJohn Loughlin
John Loughlin
Osteoarthritis is the most common form of arthritis worldwide and is a major cause of pain and disability in elderly people. The health economic burden of osteoarthritis is increasing commensurate with obesity prevalence and longevity. Osteoarthritis has a strong genetic component but the success of previous genetic studies has been restricted due to insufficient sample sizes and phenotype heterogeneity. We undertook a large genome-wide association study (GWAS) in 7410 unrelated and retrospectively and prospectively selected patients with severe osteoarthritis in the arcOGEN study, 80% of whom had undergone total joint replacement, and 11,009 unrelated controls from the UK. We replicated the most promising signals in an independent set of up to 7473 cases and 42,938 controls, from studies in Iceland, Estonia, the Netherlands, and the UK. All patients and controls were of European descent. We identified five genome-wide significant loci (binomial test p≤5·0×10(-8)) for association with osteoarthritis and three loci just below this threshold. The strongest association was on chromosome 3 with rs6976 (odds ratio 1·12 [95% CI 1·08-1·16]; p=7·24×10(-11)), which is in perfect linkage disequilibrium with rs11177. This SNP encodes a missense polymorphism within the nucleostemin-encoding gene GNL3. Levels of nucleostemin were raised in chondrocytes from patients with osteoarthritis in functional studies. Other significant loci were on chromosome 9 close to ASTN2, chromosome 6 between FILIP1 and SENP6, chromosome 12 close to KLHDC5 and PTHLH, and in another region of chromosome 12 close to CHST11. One of the signals close to genome-wide significance was within the FTO gene, which is involved in regulation of bodyweight-a strong risk factor for osteoarthritis. All risk variants were common in frequency and exerted small effects. Our findings provide insight into the genetics of arthritis and identify new pathways that might be amenable to future therapeutic intervention. arcOGEN was funded by a special purpose grant from Arthritis Research UK.

1 December 2005 in European Journal of Cancer
Verified
Journal Article
Closed access
WGWim G. Goettsch
Wim G. Goettsch
SBSteffan D. Bos
Steffan D. Bos
NBNancy Breekveldt-Postma
Nancy Breekveldt-Postma
MCMariel Casparie
Mariel Casparie
RHRon M.C. Herings
Ron M.C. Herings
Pancras C.W. HogendoornPancras C.W. Hogendoorn
Pancras C.W. Hogendoorn

23 July 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YRYolande F. M. Ramos
Yolande F. M. Ramos
WHWouter Den Hollander
Wouter Den Hollander
Judith V.M.G. BovéeJudith V.M.G. Bovée
Judith V.M.G. Bovée
Nils BomerNils Bomer
Nils Bomer
RBRuud Van Der Breggen
Ruud Van Der Breggen
IMIngrid Meulenbelt
Ingrid Meulenbelt
Identify gene expression profiles associated with OA processes in articular cartilage and determine pathways changing during the disease process. Genome wide gene expression was determined in paired samples of OA affected and preserved cartilage of the same joint using microarray analysis for 33 patients of the RAAK study. Results were replicated in independent samples by RT-qPCR and immunohistochemistry. Profiles were analyzed with the online analysis tools DAVID and STRING to identify enrichment for specific pathways and protein-protein interactions. Among the 1717 genes that were significantly differently expressed between OA affected and preserved cartilage we found significant enrichment for genes involved in skeletal development (e.g. TNFRSF11B and FRZB). Also several inflammatory genes such as CD55, PTGES and TNFAIP6, previously identified in within-joint analyses as well as in analyses comparing preserved cartilage from OA affected joints versus healthy cartilage were among the top genes. Of note was the high up-regulation of NGF in OA cartilage. RT-qPCR confirmed differential expression for 18 out of 19 genes with expression changes of 2-fold or higher, and immunohistochemistry of selected genes showed a concordant change in protein expression. Most of these changes associated with OA severity (Mankin score) but were independent of joint-site or sex. We provide further insights into the ongoing OA pathophysiological processes in cartilage, in particular into differences in macroscopically intact cartilage compared to OA affected cartilage, which seem relatively consistent and independent of sex or joint. We advocate that development of treatment could benefit by focusing on these similarities in gene expression changes and/or pathways.

11 March 2008 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
IMIngrid Meulenbelt
Ingrid Meulenbelt
JMJosine L. Min
Josine L. Min
SBSteffan Bos
Steffan Bos
NRNaghmeh Riyazi
Naghmeh Riyazi
JHJeanine J. Houwing-Duistermaat
Jeanine J. Houwing-Duistermaat
PSPieternella Eline Slagboom
Pieternella Eline Slagboom
Osteoarthritis [MIM 165720] is a common late-onset articular joint disease for which no pharmaceutical intervention is available to attenuate the cartilage degeneration. To identify a new osteoarthritis susceptibility locus, a genome-wide linkage scan and combined linkage association analysis were applied to 179 affected siblings and four trios with generalized osteoarthritis (The GARP study). We tested, for confirmation by association, 1478 subjects who required joint replacement and 734 controls in a UK population. Additional replication was tested in 1582 population-based females from the Rotterdam study that contained 94 cases with defined hip osteoarthritis and in 267 Japanese females with symptomatic hip osteoarthritis and 465 controls. Suggested evidence for linkage in the GARP study was observed on chromosome 14q32.11 (log of odds = 3.03, P = 1.9×10−4). Genotyping tagging single-nucleotide polymorphisms covering three important candidate genes revealed a common coding variant (rs225014; Thr92Ala) in the iodothyronine-deiodinase enzyme type 2 (D2) gene (DIO2 [MIM 601413]) which significantly explained the linkage signal (P = 0.006). Confirmation and replication by association in the additional osteoarthritis studies indicated a common DIO2 haplotype, exclusively containing the minor allele of rs225014 and common allele of rs12885300, with a combined recessive odds ratio of 1.79, 95% confidence interval (CI) 1.37–2.34 with P = 2.02×10−5 in female cases with advanced/symptomatic hip osteoarthritis. The gene product of this DIO2 converts intracellular pro-hormone-3,3′,5,5′-tetraiodothyronine (T4) into the active thyroid hormone 3,3′,5-triiodothyronine (T3) thereby regulating intracellular levels of active T3 in target tissues such as the growth plate. Our results indicate a new susceptibility gene (DIO2) conferring risk to osteoarthritis.

1 February 2011 in Annals of the Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
EEEvangelos Evangelou
Evangelos Evangelou
Ana M ValdesAna M Valdes
Ana M Valdes
HKHanneke J M Kerkhof
Hanneke J M Kerkhof
USUnnur Styrkarsdottir
Unnur Styrkarsdottir
YZYanYan Zhu
YanYan Zhu
TSTimothy D Spector
Timothy D Spector
Objectives Osteoarthritis (OA) is the most prevalent form of arthritis and accounts for substantial morbidity and disability, particularly in older people. It is characterised by changes in joint structure, including degeneration of the articular cartilage, and its aetiology is multifactorial with a strong postulated genetic component. Methods A meta-analysis was performed of four genome-wide association (GWA) studies of 2371 cases of knee OA and 35 909 controls in Caucasian populations. Replication of the top hits was attempted with data from 10 additional replication datasets. Results With a cumulative sample size of 6709 cases and 44 439 controls, one genome-wide significant locus was identified on chromosome 7q22 for knee OA (rs4730250, p=9.2×10−9), thereby confirming its role as a susceptibility locus for OA. Conclusion The associated signal is located within a large (500 kb) linkage disequilibrium block that contains six genes: PRKAR2B (protein kinase, cAMP-dependent, regulatory, type II, β), HPB1 (HMG-box transcription factor 1), COG5 (component of oligomeric golgi complex 5), GPR22 (G protein-coupled receptor 22), DUS4L (dihydrouridine synthase 4-like) and BCAP29 (B cell receptor-associated protein 29). Gene expression analyses of the (six) genes in primary cells derived from different joint tissues confirmed expression of all the genes in the joint environment.

1 December 2014 in Annals of the Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
WHW Den Hollander
W Den Hollander
YRYolande F. M. Ramos
Yolande F. M. Ramos
SBS D Bos
S D Bos
Nils BomerNils Bomer
Nils Bomer
RBR van der Breggen
R van der Breggen
IMIngrid Meulenbelt
Ingrid Meulenbelt
Objectives To elucidate the functional epigenomic landscape of articular cartilage in osteoarthritis (OA) affected knee and hip joints in relation to gene expression. Methods Using Illumina Infinium HumanMethylation450 BeadChip arrays, genome-wide DNA methylation was measured in 31 preserved and lesioned cartilage sample pairs (14 knees and 17 hips) from patients who underwent a total joint replacement due to primary OA. Using previously published genome-wide expression data of 33 pairs of cartilage samples, of which 13 pairs were overlapping with the current methylation dataset, we assessed gene expression differences in differentially methylated regions (DMRs). Results Principal component analysis of the methylation data revealed distinct clustering of knee and hip samples, irrespective of OA pathophysiology. A total of 6272 CpG dinucleotides were differentially methylated between the two joints, comprising a total of 357 DMRs containing 1817 CpGs and 245 unique genes. Enrichment analysis of genes proximal of the DMRs revealed significant enrichment for developmental pathways and homeobox (HOX) genes. Subsequent transcriptomic analysis of DMR genes exposed distinct knee and hip expression patterns. Conclusions Our findings reveal consistent DMRs between knee and hip articular cartilage that marked transcriptomic differences among HOX genes, which were not reflecting the temporal sequential HOX expression pattern during development. This implies distinct mechanisms for maintaining cartilage integrity in adulthood, thereby contributing to our understanding of cartilage homeostasis and future tissue regeneration approaches.